PARP Inhibitors May Bring New Hope to Patients With Small Cell Lung Cancer
July 17th 2018Investigators at The University of Texas MD Anderson Cancer Center in Houston discovered that adding the PARP inhibitor veliparib to a standard chemotherapy regimen improved overall responses rates (ORR) in patients with relapsed small cell lung cancer (SCLC).
Lymphoma Subgroup Experiences Durable Responses from Kymriah Treatment
June 20th 2018Treatment with chimeric antigen receptor (CAR)-T cell therapy showed encouraging rates of durable responses among adult patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL), according to updated data from the pivotal JULIET trial.
Patients With Myeloma Precursor Report Worse Quality of Life
June 8th 2018Cancer affects many aspects of a person’s life, such as the overall quality of their day-to-day living, but what if a person didn’t have the full-blown disease already? Could a precursor or asymptomatic stage of the disease still burden them?
Investigational Drug Shows Promise in Patients with Metastatic Urothelial Cancer
June 5th 2018Enfortumab vedotin may be a potential novel therapy for patients with locally advanced or metastatic urothelial cancer, according to updated phase 1 study findings presented during the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.
High Percentage of Caregivers Report Feeling Depressed, Study Finds
May 5th 2018Eighty-nine percent of caregivers of young adult colorectal cancer survivors are depressed because they can’t take the pain away, according to findings from the Raymond Foundation, an advocacy organization that aims to eradicate colon cancer.
New Guidelines Aim to Improve Quality of Life For Patients With Advanced Lung Cancer
April 12th 2018Some patients with incurable non-small cell lung cancer (NSCLC) should receive chemotherapy concurrent with palliative thoracic radiation therapy, according to an updated guideline released by the American Society for Radiation Oncology (ASTRO).